www. Alfred. TV READ ME FIRST Join me with Dr. Howard Lederman from Johns Hopkins Medicine as he provides us with an overview of the genetic disorder, Ataxia Telangiectasia, better known as “AT”. Dr. Lederman’s titles at Johns Hopkins Medicine include: • Professor of Pediatrics • Director, Immunodeficiency Clinic • Director, Ataxia-Telangiectasia Clinical Center • Director, Pediatric Immunology Laboratory AT can be referred to as a “gateway gene”, with its mutation, known as “ATM”, opening the doors to many other diseases, including: • Diabetes • Alzheimer’s • Cerebral Palsy • Cystic Fibrosis • Breast Cancer • Immune Deficiency Dr. Lederman’s leading-edge research on AT, with his team at Johns Hopkins Medicine, may also lead to uncovering cures for these other diseases. There are approximately 500 individuals afflicted with AT in the United States. It is a rare, genetic disorder. Also joining us in this video is Jared Digby, with his mother, Pamela, who is afflicted with AT. Pamela and her husband both were carries of the mutated AT gene, and Jared, unfortunately, got a ‘double dose” at the genetic level, and suffers with the disorder. Jared’s sister is ok. Jared is an avid MacPro user, and he with his family are participating in a Disney Marathon this Labor Day weekend, 2009, to continue fundraising efforts for continued AT research. Below are website links used during this webcast: John Hopkins Medicine www. hopkinsmedicine. org Howard Mark Lederman, MD PhD bit. ly Johns . . .








Fri, Jul 9, 2010
Breast Cancer